I don’t agree
Why?
Because of the Stella Results
This is the Holy Grail for treating neuro indications worth $billions…and no other rival biotechs are even close…
The cr was oversubscribed and in the US there was a scramble to get the ATM allocation..
and as DS has stated 2025 is the year for ATH..
I'm excited…
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(5.56%) |
Mkt cap ! $86.71M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $30.79K | 3.264M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 11049841 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 5989653 | 10 |
View Market Depth
| Last trade - 13.17pm 27/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |